• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home News

Jay Bhattacharya on Public Health

by
October 12, 2021
in News
0
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Our guest is Jay Bhattacharya, Professor of Medicine and Health Policy at Stanford University. Professor Bhattacharya is also research associate at the National Bureau of Economics Research, a senior fellow at the Stanford Institute for Economic Policy Research, and director of the Stanford Center on the Demography of Health and Aging.

Dr. Bhattacharya gained international prominence during the COVID pandemic for his contributions to determining the infection fatality rate of the virus, and for his criticism on broad coercive lockdown policies and vaccine mandates. Along with colleagues Martin Kulldorff and Sunetra Gupta, he wrote the Great Barrington Declaration of focused protection which has garnered 860,000 signatures to date.

SHOW NOTES​

Jay Bhattacharya: Twitter and Stanford page

Watch the episode on our YouTube channel

Previous Post

Fabrice Testa on Super Entrepreneurship

Next Post

What the New Nobel Winners Get Wrong about Economics

Next Post
What the New Nobel Winners Get Wrong about Economics

What the New Nobel Winners Get Wrong about Economics

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.